Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinal Cone Photoreceptor Cells | 21 | 2013 | 43 | 4.420 |
Why?
|
| Contrast Sensitivity | 22 | 2013 | 70 | 3.480 |
Why?
|
| Electroretinography | 29 | 2013 | 77 | 3.220 |
Why?
|
| Retinitis Pigmentosa | 21 | 2013 | 35 | 2.580 |
Why?
|
| Visual Pathways | 14 | 2011 | 153 | 2.450 |
Why?
|
| Visual Acuity | 26 | 2011 | 203 | 1.810 |
Why?
|
| Papillomavirus Vaccines | 8 | 2019 | 57 | 1.660 |
Why?
|
| Papillomavirus Infections | 8 | 2019 | 264 | 1.280 |
Why?
|
| Photic Stimulation | 26 | 2013 | 503 | 1.260 |
Why?
|
| Vaccination | 4 | 2016 | 280 | 1.230 |
Why?
|
| Adaptation, Ocular | 7 | 2012 | 37 | 1.220 |
Why?
|
| Light | 8 | 2012 | 292 | 1.120 |
Why?
|
| Retinal Diseases | 5 | 2011 | 90 | 0.970 |
Why?
|
| Color Vision | 2 | 2012 | 15 | 0.800 |
Why?
|
| Adult | 63 | 2021 | 26953 | 0.780 |
Why?
|
| Vulvar Neoplasms | 1 | 2021 | 19 | 0.770 |
Why?
|
| Sensory Thresholds | 16 | 2013 | 55 | 0.760 |
Why?
|
| Evoked Potentials, Visual | 6 | 2013 | 87 | 0.760 |
Why?
|
| Alphapapillomavirus | 1 | 2021 | 44 | 0.740 |
Why?
|
| Vision, Ocular | 5 | 2006 | 71 | 0.730 |
Why?
|
| Cancer Survivors | 1 | 2021 | 63 | 0.710 |
Why?
|
| Visual Fields | 15 | 2011 | 98 | 0.680 |
Why?
|
| Retinal Ganglion Cells | 4 | 2013 | 71 | 0.660 |
Why?
|
| Neoplasms, Second Primary | 1 | 2021 | 240 | 0.650 |
Why?
|
| Pattern Recognition, Visual | 5 | 2010 | 156 | 0.640 |
Why?
|
| Middle Aged | 51 | 2019 | 26347 | 0.630 |
Why?
|
| Automobile Driving | 3 | 2016 | 31 | 0.630 |
Why?
|
| Retinal Degeneration | 6 | 2001 | 29 | 0.610 |
Why?
|
| Male | 64 | 2021 | 42967 | 0.590 |
Why?
|
| Psychophysics | 9 | 2011 | 80 | 0.570 |
Why?
|
| Vision Disorders | 6 | 2011 | 74 | 0.550 |
Why?
|
| Vaccination Refusal | 1 | 2016 | 10 | 0.540 |
Why?
|
| Pediatricians | 1 | 2016 | 17 | 0.530 |
Why?
|
| Transportation | 1 | 2016 | 20 | 0.530 |
Why?
|
| Communicable Disease Control | 1 | 2016 | 52 | 0.530 |
Why?
|
| Professional-Family Relations | 1 | 2016 | 54 | 0.520 |
Why?
|
| Female | 58 | 2021 | 46894 | 0.510 |
Why?
|
| Space Perception | 4 | 1999 | 117 | 0.500 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 43 | 0.500 |
Why?
|
| X Chromosome | 6 | 2002 | 153 | 0.490 |
Why?
|
| Humans | 76 | 2021 | 90640 | 0.480 |
Why?
|
| Papillomaviridae | 4 | 2021 | 156 | 0.460 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2019 | 537 | 0.460 |
Why?
|
| Genetic Linkage | 6 | 2002 | 624 | 0.450 |
Why?
|
| Interneurons | 5 | 2012 | 95 | 0.440 |
Why?
|
| Parents | 1 | 2016 | 291 | 0.430 |
Why?
|
| Feedback | 3 | 2009 | 135 | 0.430 |
Why?
|
| Paraneoplastic Syndromes | 2 | 2004 | 16 | 0.420 |
Why?
|
| Orientation | 3 | 2010 | 119 | 0.420 |
Why?
|
| Optic Atrophy | 1 | 2012 | 4 | 0.420 |
Why?
|
| Influenza, Human | 1 | 2016 | 341 | 0.410 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 2019 | 298 | 0.410 |
Why?
|
| Neoplasms | 2 | 2021 | 3030 | 0.400 |
Why?
|
| Vision Tests | 7 | 2011 | 20 | 0.390 |
Why?
|
| Visual Field Tests | 8 | 2007 | 15 | 0.390 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2011 | 6 | 0.380 |
Why?
|
| Astigmatism | 1 | 2011 | 10 | 0.380 |
Why?
|
| Dark Adaptation | 6 | 2013 | 12 | 0.380 |
Why?
|
| Form Perception | 3 | 1997 | 37 | 0.380 |
Why?
|
| Fovea Centralis | 4 | 2005 | 21 | 0.370 |
Why?
|
| Nerve Fibers | 1 | 2011 | 48 | 0.370 |
Why?
|
| Child | 15 | 2021 | 7219 | 0.340 |
Why?
|
| Night Blindness | 4 | 2013 | 4 | 0.340 |
Why?
|
| Genetic Diseases, X-Linked | 2 | 2013 | 35 | 0.320 |
Why?
|
| Communication | 1 | 2012 | 462 | 0.310 |
Why?
|
| Melanoma | 2 | 2004 | 474 | 0.310 |
Why?
|
| Photoreceptor Cells, Vertebrate | 3 | 2007 | 9 | 0.300 |
Why?
|
| Physician-Patient Relations | 2 | 2014 | 625 | 0.300 |
Why?
|
| Skin Neoplasms | 2 | 2004 | 601 | 0.290 |
Why?
|
| Adolescent | 20 | 2019 | 9354 | 0.270 |
Why?
|
| Young Adult | 8 | 2019 | 6426 | 0.270 |
Why?
|
| Retinoschisis | 1 | 2005 | 3 | 0.250 |
Why?
|
| Fourier Analysis | 4 | 2012 | 128 | 0.230 |
Why?
|
| Multimedia | 2 | 2012 | 9 | 0.200 |
Why?
|
| Macular Degeneration | 2 | 2001 | 61 | 0.200 |
Why?
|
| Antiviral Agents | 1 | 2005 | 488 | 0.190 |
Why?
|
| SEER Program | 1 | 2021 | 202 | 0.180 |
Why?
|
| Retina | 4 | 2013 | 221 | 0.180 |
Why?
|
| Case-Control Studies | 6 | 2013 | 1873 | 0.180 |
Why?
|
| Incidence | 3 | 2021 | 1594 | 0.170 |
Why?
|
| Risk | 1 | 2021 | 656 | 0.170 |
Why?
|
| Trust | 2 | 2019 | 97 | 0.160 |
Why?
|
| Tomography, Optical Coherence | 3 | 2011 | 141 | 0.160 |
Why?
|
| Health Education | 1 | 2019 | 105 | 0.150 |
Why?
|
| Motion Perception | 1 | 1999 | 106 | 0.150 |
Why?
|
| Skating | 1 | 2017 | 2 | 0.140 |
Why?
|
| Hamstring Muscles | 1 | 2017 | 2 | 0.140 |
Why?
|
| Pyomyositis | 1 | 2017 | 2 | 0.140 |
Why?
|
| Thigh | 1 | 2017 | 39 | 0.140 |
Why?
|
| Immunization Programs | 2 | 2014 | 25 | 0.140 |
Why?
|
| Lens, Crystalline | 2 | 1998 | 69 | 0.140 |
Why?
|
| Artifacts | 1 | 1998 | 246 | 0.140 |
Why?
|
| Physicians' Offices | 1 | 2016 | 3 | 0.140 |
Why?
|
| Scattering, Radiation | 4 | 2005 | 117 | 0.140 |
Why?
|
| Chemotherapy-Induced Febrile Neutropenia | 1 | 2016 | 6 | 0.130 |
Why?
|
| Blood Culture | 1 | 2016 | 11 | 0.130 |
Why?
|
| Point Mutation | 3 | 2011 | 246 | 0.130 |
Why?
|
| Escherichia coli Infections | 1 | 2016 | 34 | 0.130 |
Why?
|
| Refractive Errors | 2 | 2005 | 4 | 0.130 |
Why?
|
| Mutation, Missense | 2 | 2013 | 282 | 0.130 |
Why?
|
| Time Factors | 4 | 2009 | 5366 | 0.130 |
Why?
|
| Communicable Diseases | 1 | 2016 | 64 | 0.130 |
Why?
|
| Vaginal Smears | 2 | 2013 | 71 | 0.120 |
Why?
|
| Health Services Needs and Demand | 1 | 2016 | 107 | 0.120 |
Why?
|
| Bacteremia | 1 | 2016 | 103 | 0.120 |
Why?
|
| United States | 5 | 2016 | 7142 | 0.120 |
Why?
|
| School Health Services | 1 | 2014 | 16 | 0.120 |
Why?
|
| Sexually Transmitted Diseases, Viral | 1 | 2014 | 3 | 0.120 |
Why?
|
| Chicago | 2 | 2016 | 1441 | 0.110 |
Why?
|
| Guideline Adherence | 1 | 2016 | 232 | 0.110 |
Why?
|
| Schools | 1 | 2014 | 79 | 0.110 |
Why?
|
| Lighting | 2 | 2006 | 33 | 0.110 |
Why?
|
| Risk Factors | 3 | 2021 | 5583 | 0.110 |
Why?
|
| Algorithms | 3 | 2013 | 1919 | 0.110 |
Why?
|
| National Health Programs | 1 | 2013 | 19 | 0.110 |
Why?
|
| Aged | 13 | 2016 | 19424 | 0.110 |
Why?
|
| Attitude of Health Personnel | 2 | 2008 | 652 | 0.110 |
Why?
|
| Myopia | 1 | 2013 | 10 | 0.110 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2013 | 8 | 0.110 |
Why?
|
| Escherichia coli | 1 | 2016 | 613 | 0.100 |
Why?
|
| Mother-Child Relations | 1 | 2012 | 26 | 0.100 |
Why?
|
| Differential Threshold | 2 | 2003 | 12 | 0.100 |
Why?
|
| Electrodes, Implanted | 1 | 2013 | 185 | 0.100 |
Why?
|
| Physician's Role | 1 | 2014 | 177 | 0.100 |
Why?
|
| Proteoglycans | 1 | 2013 | 124 | 0.100 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2014 | 132 | 0.100 |
Why?
|
| Parenting | 1 | 2012 | 70 | 0.100 |
Why?
|
| RNA, Viral | 1 | 2013 | 320 | 0.100 |
Why?
|
| Aberrometry | 1 | 2011 | 1 | 0.100 |
Why?
|
| Eyeglasses | 1 | 2011 | 8 | 0.090 |
Why?
|
| Vision Screening | 1 | 1991 | 2 | 0.090 |
Why?
|
| Education, Medical, Continuing | 1 | 2012 | 106 | 0.090 |
Why?
|
| Mothers | 1 | 2012 | 145 | 0.090 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 364 | 0.090 |
Why?
|
| GTP Phosphohydrolases | 1 | 2011 | 75 | 0.090 |
Why?
|
| Mouth Neoplasms | 1 | 2013 | 199 | 0.090 |
Why?
|
| Choroideremia | 2 | 2002 | 2 | 0.090 |
Why?
|
| Mitochondrial Proteins | 1 | 2011 | 128 | 0.090 |
Why?
|
| Models, Neurological | 1 | 2013 | 412 | 0.090 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2012 | 263 | 0.080 |
Why?
|
| Motivation | 1 | 2012 | 303 | 0.080 |
Why?
|
| Retinal Bipolar Cells | 1 | 2009 | 4 | 0.080 |
Why?
|
| Time Perception | 1 | 2009 | 24 | 0.080 |
Why?
|
| Retinal Rod Photoreceptor Cells | 2 | 2002 | 9 | 0.080 |
Why?
|
| Public Opinion | 1 | 2008 | 46 | 0.080 |
Why?
|
| Mass Screening | 1 | 2013 | 643 | 0.080 |
Why?
|
| Pediatrics | 2 | 2008 | 361 | 0.070 |
Why?
|
| Judgment | 1 | 2008 | 68 | 0.070 |
Why?
|
| Eye Proteins | 2 | 1998 | 128 | 0.070 |
Why?
|
| Cataract | 2 | 2005 | 87 | 0.070 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 318 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 1056 | 0.070 |
Why?
|
| Genitalia | 1 | 2005 | 21 | 0.060 |
Why?
|
| Models, Psychological | 1 | 2006 | 160 | 0.060 |
Why?
|
| Pipecolic Acids | 3 | 2010 | 14 | 0.060 |
Why?
|
| Nonlinear Dynamics | 1 | 2005 | 73 | 0.060 |
Why?
|
| Immunization | 1 | 2005 | 163 | 0.060 |
Why?
|
| Heterozygote | 2 | 2003 | 373 | 0.060 |
Why?
|
| Excitatory Amino Acid Antagonists | 3 | 2010 | 80 | 0.060 |
Why?
|
| Geniculate Bodies | 1 | 2005 | 140 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2011 | 1232 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 2422 | 0.060 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2005 | 99 | 0.060 |
Why?
|
| Glaucoma | 1 | 2003 | 35 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2004 | 898 | 0.050 |
Why?
|
| Recurrence | 1 | 2005 | 1162 | 0.050 |
Why?
|
| Mycoses | 1 | 2002 | 46 | 0.050 |
Why?
|
| Reference Values | 2 | 2001 | 662 | 0.050 |
Why?
|
| Kinetics | 1 | 2004 | 1550 | 0.050 |
Why?
|
| Virus Diseases | 1 | 2002 | 101 | 0.050 |
Why?
|
| Psychometrics | 2 | 2007 | 332 | 0.050 |
Why?
|
| Bacterial Infections | 1 | 2002 | 185 | 0.040 |
Why?
|
| Aminobutyrates | 2 | 2010 | 13 | 0.040 |
Why?
|
| Excitatory Amino Acid Agonists | 2 | 2010 | 45 | 0.040 |
Why?
|
| Codon | 1 | 1998 | 123 | 0.040 |
Why?
|
| Child, Preschool | 4 | 2016 | 3767 | 0.040 |
Why?
|
| Saccades | 1 | 1998 | 68 | 0.040 |
Why?
|
| Vision, Monocular | 1 | 1997 | 15 | 0.040 |
Why?
|
| Intermediate Filament Proteins | 1 | 1997 | 35 | 0.030 |
Why?
|
| Phenylalanine | 1 | 1997 | 36 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 595 | 0.030 |
Why?
|
| Serine | 1 | 1997 | 105 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2017 | 160 | 0.030 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 2 | 2005 | 16 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 1997 | 206 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2007 | 2782 | 0.030 |
Why?
|
| Prognosis | 2 | 2013 | 3813 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 1998 | 679 | 0.030 |
Why?
|
| Depth Perception | 1 | 1995 | 19 | 0.030 |
Why?
|
| Perceptual Disorders | 1 | 1995 | 12 | 0.030 |
Why?
|
| Optic Nerve Diseases | 1 | 1995 | 18 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2002 | 914 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2013 | 923 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 1997 | 434 | 0.030 |
Why?
|
| Genital Neoplasms, Male | 1 | 2014 | 11 | 0.030 |
Why?
|
| Human papillomavirus 18 | 1 | 2014 | 16 | 0.030 |
Why?
|
| Human papillomavirus 16 | 1 | 2014 | 38 | 0.030 |
Why?
|
| Treatment Refusal | 1 | 2014 | 62 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 1997 | 511 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2019 | 2670 | 0.030 |
Why?
|
| Perceptual Masking | 1 | 2013 | 10 | 0.030 |
Why?
|
| Pedigree | 3 | 2002 | 969 | 0.030 |
Why?
|
| Adolescent Behavior | 1 | 2014 | 109 | 0.030 |
Why?
|
| Genital Neoplasms, Female | 1 | 2014 | 110 | 0.030 |
Why?
|
| Prospective Studies | 4 | 2007 | 4348 | 0.030 |
Why?
|
| Fundus Oculi | 3 | 1998 | 33 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2013 | 120 | 0.030 |
Why?
|
| Rats | 2 | 2009 | 4061 | 0.030 |
Why?
|
| Informed Consent | 1 | 2014 | 277 | 0.020 |
Why?
|
| Sexual Behavior | 1 | 2014 | 316 | 0.020 |
Why?
|
| Exons | 1 | 2013 | 453 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1991 | 270 | 0.020 |
Why?
|
| Retinal Neurons | 1 | 2010 | 11 | 0.020 |
Why?
|
| Intravitreal Injections | 1 | 2010 | 75 | 0.020 |
Why?
|
| Vitreous Body | 1 | 2009 | 54 | 0.020 |
Why?
|
| Rabbits | 1 | 2010 | 641 | 0.020 |
Why?
|
| Injections | 1 | 2009 | 116 | 0.020 |
Why?
|
| Illinois | 1 | 1991 | 491 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 1500 | 0.020 |
Why?
|
| Sexual Abstinence | 1 | 2008 | 10 | 0.020 |
Why?
|
| Papanicolaou Test | 1 | 2008 | 38 | 0.020 |
Why?
|
| Parental Consent | 1 | 2008 | 36 | 0.020 |
Why?
|
| Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2008 | 5 | 0.020 |
Why?
|
| Visual Perception | 1 | 2011 | 327 | 0.020 |
Why?
|
| Family Practice | 1 | 2008 | 84 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2008 | 50 | 0.020 |
Why?
|
| Religion | 1 | 2008 | 88 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 2019 | 0.020 |
Why?
|
| Health Surveys | 1 | 2008 | 239 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 1242 | 0.020 |
Why?
|
| Animals | 3 | 2010 | 27715 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 748 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2003 | 1738 | 0.010 |
Why?
|
| Tonometry, Ocular | 1 | 2003 | 11 | 0.010 |
Why?
|
| Intraocular Pressure | 1 | 2003 | 59 | 0.010 |
Why?
|
| North Carolina | 1 | 2002 | 50 | 0.010 |
Why?
|
| Opportunistic Infections | 1 | 2002 | 60 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2002 | 362 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2002 | 982 | 0.010 |
Why?
|
| Glare | 1 | 1998 | 1 | 0.010 |
Why?
|
| Valine | 1 | 1998 | 62 | 0.010 |
Why?
|
| Glycine | 1 | 1998 | 98 | 0.010 |
Why?
|
| Peripherins | 1 | 1997 | 4 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1997 | 49 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1997 | 26 | 0.010 |
Why?
|
| Half-Life | 1 | 1997 | 97 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 1998 | 531 | 0.010 |
Why?
|
| Deafness | 1 | 1997 | 48 | 0.010 |
Why?
|
| Self Disclosure | 1 | 1997 | 32 | 0.010 |
Why?
|
| Family | 1 | 1998 | 324 | 0.010 |
Why?
|
| Photoreceptor Cells | 1 | 1996 | 21 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2002 | 2502 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2002 | 9330 | 0.010 |
Why?
|
| Infant | 1 | 2002 | 3184 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2002 | 2891 | 0.010 |
Why?
|
| Autoantibodies | 1 | 1996 | 275 | 0.010 |
Why?
|
| Electrooculography | 1 | 1993 | 21 | 0.010 |
Why?
|
| Photography | 1 | 1993 | 38 | 0.010 |
Why?
|
| Accidents, Traffic | 1 | 1992 | 98 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1992 | 591 | 0.010 |
Why?
|
| DNA | 1 | 1997 | 1314 | 0.010 |
Why?
|
| Aging | 1 | 1993 | 730 | 0.000 |
Why?
|
| Computer Simulation | 1 | 1992 | 1103 | 0.000 |
Why?
|
| Signal Transduction | 1 | 1996 | 3431 | 0.000 |
Why?
|